Repatha

Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Fierce Pharma
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Supreme Court
Praluent
Repatha
Flag link:
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Amgen
Repatha
type 2 diabetes
diabetes
hypercholesterolemia
ADA
Flag link:
Are These Disappointing Drugs Back on Track to Billions?
Are These Disappointing Drugs Back on Track to Billions?
Motley Fool
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Praluent
Repatha
Flag link:
Amgen focuses on migraine launch as growth remains slow
Amgen focuses on migraine launch as growth remains slow
Biopharma Dive
Amgen
earnings
Repatha
Kyprolis
Prolia
Xgeva
Flag link:
Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Xtalks
Amgen
Repatha
outcome-based pricing
drug pricing
patients
Flag link:
Amgen's money-back offer on Repatha isn't all that meaningful, researchers find
Amgen's money-back offer on Repatha isn't all that meaningful, researchers find
Biopharma Dive
Amgen
Repatha
Flag link:
Amgen darkens the mood in new Repatha TV ads, warning of heart and stroke risks
Amgen darkens the mood in new Repatha TV ads, warning of heart and stroke risks
Fierce Pharma
Amgen
Repatha
DTC ads
heart attack
stroke
Flag link:
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Fierce Pharma
Amgen
Repatha
Sensipar
generics
Sanofi
Regeneron
Praluent
Flag link:
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
cholesterol
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
Flag link:
What to Expect From Amgen, Inc. in 2018
What to Expect From Amgen, Inc. in 2018
Motley Fool
Amgen
Enbrel
Neulasta
Aranesp
Epogen
Neupogen
Prolia
Repatha
CAR-T
Flag link:
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Fierce Pharma
China
Opdivo
Repatha
Lynparza
drug approvals
Bristol-Myers Squibb
Amgen
AstraZeneca
Eli Lilly
Gilead Sciences
Flag link:
FDA approves heart protection claims for Amgen cholesterol drug
FDA approves heart protection claims for Amgen cholesterol drug
Reuters
FDA
Amgen
cholesterol
Repatha
Flag link:
PCSK9 court saga drags on for Sanofi, Regeneron and Amgen
PCSK9 court saga drags on for Sanofi, Regeneron and Amgen
Biopharma Dive
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
Praluent
Repatha
Flag link:
U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent
U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent
Yahoo/Reuters
Sanofi
Regeneron
Praluent
Repatha
patents
Flag link:
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Sanofi
Amgen
PCSK9 inhibitors
diabetes
Regeneron
Praluent
Repatha
Flag link:
Insurers, doctors battle over new heart disease drugs
Insurers, doctors battle over new heart disease drugs
CNBC
insurers
cardiovascular disease
statins
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Flag link:
In cost debate, Amgen stands by Repatha's value
In cost debate, Amgen stands by Repatha's value
BioPharma Dive
Amgen
Repatha
drug pricing
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Flag link:
Amgen Remains A Standout Among Biotechs
Amgen Remains A Standout Among Biotechs
Forbes
Amgen
Repatha
biotech
Flag link:
Drugmakers face challenges marketing new heart drugs
Drugmakers face challenges marketing new heart drugs
Medical Marketing and Media
drug marketing
Amgen
Repatha
Novartis
Entresto
Ilaris
canakinumab
Merck
Anacetrapib
Flag link:
Amgen inks first money-back guarantee for Repatha
Amgen inks first money-back guarantee for Repatha
BioPharma Dive
Amgen
Repatha
insurers
Flag link:

Pages